USANA Health Sciences, Inc.
USNA
$20.03
$0.231.16%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.88% | 2.75% | -2.69% | -7.22% | -7.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.88% | 2.75% | -2.69% | -7.22% | -7.10% |
| Cost of Revenue | 15.17% | 7.24% | -0.38% | -8.76% | -8.75% |
| Gross Profit | 3.68% | 1.69% | -3.23% | -6.86% | -6.70% |
| SG&A Expenses | 10.77% | 6.43% | 1.57% | -3.73% | -6.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.70% | 6.61% | 1.16% | -4.80% | -6.80% |
| Operating Income | -49.20% | -33.36% | -36.94% | -28.74% | -9.92% |
| Income Before Tax | -48.37% | -31.62% | -34.71% | -25.48% | -6.20% |
| Income Tax Expenses | -20.86% | -24.40% | -20.33% | -11.31% | -1.64% |
| Earnings from Continuing Operations | -67.69% | -36.78% | -43.80% | -34.06% | -9.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.74% | -38.06% | -43.67% | -34.11% | -9.15% |
| EBIT | -49.20% | -33.36% | -36.94% | -28.74% | -9.92% |
| EBITDA | -27.10% | -18.10% | -25.53% | -23.55% | -8.33% |
| EPS Basic | -68.56% | -37.13% | -43.14% | -33.55% | -8.57% |
| Normalized Basic EPS | -48.46% | -31.84% | -33.99% | -24.89% | -5.58% |
| EPS Diluted | -68.91% | -37.24% | -43.46% | -33.79% | -8.50% |
| Normalized Diluted EPS | -48.36% | -31.61% | -33.81% | -24.90% | -5.52% |
| Average Basic Shares Outstanding | -2.11% | -1.30% | -0.89% | -0.87% | -0.69% |
| Average Diluted Shares Outstanding | -2.32% | -1.66% | -1.19% | -0.95% | -0.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |